comparemela.com
Home
Live Updates
Danielr Kaul - Breaking News
Pages:
Latest Breaking News On - Danielr kaul - Page 1 : comparemela.com
New Antiviral Option for CMV Prophylaxis After Kidney Transplant
Letermovir proved noninferior to standard of care in clinical trial
United states
Jeff minerd
Ajit limaye
Danielr kaul
Zoe raglow
Letermovir prevymis
University of washington medicine in seattle
Washington medicine
Michigan medical school
Ann arbor
A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant | Infectious Diseases | JAMA
Cytomegalovirus (CMV) is among the most consequential infections affecting solid organ transplant recipients. In addition to the direct consequences of viral in
United states
Ann arbor
Danielr kaul
Division of infectious diseases
Drug administration
E medical center dr
University of michigan medical school
Infectious diseases
Michigan medical school
Interest disclosures
Letermovir Approved for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
The antiviral letermovir has received a new FDA indication as prophylaxis for recipients of a cytomegalovirus (CMV)-seropositive kidney transplant.
District of columbia
United states
San diego
Danielr kaul
Zoe raglow
Ajitp limaye
Division of infectious disease
Merck sharp dohme
American transplant congress
Transplant congress
Infectious disease
Michigan medical school
Ann arbor
Merck sharp
vimarsana © 2020. All Rights Reserved.